National and Kapodistrian University of Athens
Η μοριακή σταδιοποίηση με multiplex PCR του καρκίνου του προστάτη
Abstract
dc:descriptionMetastatic disease is the most common cause of cancer-related death in patients with prostate cancer. A considerable body of evidence indicates that tumor cells are shed from a primary tumor mass at the earliest stages of malignant progression. Some of these cells, will travel via the peripheral blood to sites anatomically distant from the primary tumor and form metastases. The cells that escape from the primary tumor and settle down at a secondary site to cause metastasis are called Circulating Tumor Cells (CTCs). These cells are understood to be a source of eventual lethal metastases, the major cause of treatment failure in cancer patients. Detection of CTCs in cancer patients holds tremendous “promise” in terms of identifying the potential for metastatic disease at very early stages, managing risk stratification in the adjuvant setting, monitoring response to treatment and disease recurrence, and the prospective development of more effective and better tailored anticancer therapies for individual patients based on molecular characterization of CTCs. A vast plethora of research studies have concluded that the presence of CTCs in the peripheral blood is of prognostic significance in different types of solid tumors. Furthermore, when the limitations of traditional parameters, such as, PSA value, GS, and clinical stage are considered, it became evident that additional markers are urgently needed to improve the accuracy of outcome prediction after definite treatment, especially in high-risk prostate cancer. Multiplex PCR is a mature variant of PCR in which more than one locus are simultaneously amplified in the same reaction by including more than one pair of primers. The main purpose of this research was to develop a multiplex RT-PCR assay, for the first time, which enables the stimultaneous detection at the peripheral blood, of three prostate cancer specific nucleic acid and two biomarkers associated with malignancies, and to validate this technique as an auxiliary method in the clinical staging of prostate cancer patients. The study panel consisted of 5 mRNA tumor markers: prostate specific antigen (PSA), prostate specific membrane antigen (PSMA), prostate stem cell antigen (PSCA), parathyroid hormone-related protein (PTHrP), and cytokeratin 19 (CK19), all shown previously to be significantly expressed in prostate cancer. In conclusion, after the successful development of this technique, it could be said that the results of this study demonstrate the superiority of Multiplex RT-PCR compared to individual marker expression analysis, and could provide a new, clinical tool to complement the existing PSA tests and improve prostate cancer clinical staging modalities.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Panteleakou, Zacharoula
- Παντελεάκου, Ζαχαρούλα
Subjects
dc:subject × 20- Καρκίνος προστάτη
- Κυκλοφορούντα καρκινικά κύτταρα
- Μοριακή σταδιοποίηση
- Μεταστάσεις
- Πολλαπλή αντίδραση πολυμεράσης
- Περιφερικό αίμα
- Διάγνωση
- Ανίχνευση
- Prostate cancer
- Circulating tumor cells
- Molecular staging
- Metastases
- Multiplex PCR
- Peripheral blood
- Diagnosis
- Detection
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/23829